文献求助，关于direct reprograming，附链接

flydayzhu

( e+ ]; K8 J5 U) d9 J

3 R: z1 l% y9 v  Q  e) ?. U麻烦大家了，最好是能够提供杂志版的，看着相对舒服点，谢谢~
/ X2 w) `; [( d( G" Q2 o% u/ E8 V/ E( C3 L5 O! n) z
1.Promotion of direct reprogramming by transformation-deficient Myc.
) ~+ a9 l0 ~# M& l) X6 qNakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S.( D* t# x" b7 K4 I, r, c( ]
" i0 {; I* w, x" d! p  L
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. nakagawa@cira.kyoto-u.ac.jp& t) S" E7 M/ B* g: \/ k
http://www.ncbi.nlm.nih.gov/pubmed/20660764
- [0 v" ?. y% I9 |& a9 b* K: O2 f$ ]: P7 O: E4 O
2.Stem Cells. 2010 Aug;28(8):1349-54.' Z$ o2 H' Z: i) e% u( |3 O4 N
Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.; m# j# U2 z( ?1 `( M6 a
Ron-Bigger S, Bar-Nur O, Isaac S, Bocker M, Lyko F, Eden A.9 S4 S; W2 k) F
3 S( o' v9 f. _& u8 c
Departments of Cell and Developmental Biology, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
) e. O( v" j) d' Thttp://www.ncbi.nlm.nih.gov/pubmed/205720158 D$ y0 M# y% p* ?% W! F

, r( b/ p0 V, H  s$ A. u. Q+ ~3.Nat Biotechnol. 2010 May;28(5):521-6. Epub 2010 May 2.
+ @9 @* ^/ ]' N. hDynamic single-cell imaging of direct reprogramming reveals an early specifying event.
% C3 X' L8 x. A: j8 B  E1 K5 D1 t7 _Smith ZD, Nachman I, Regev A, Meissner A.; Q7 i3 w& q% [$ ]' l- m

* j# y( r' o4 J: NBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
& E! R1 x5 i; c( ?: fComment in:
5 K  }+ Y/ _: g% T' b' G& F5 I
8 D$ E& r9 }6 ~: G% i0 w. iRegen Med. 2010 Jul;5(4):501-3.; R7 J: |4 F0 Z
http://www.ncbi.nlm.nih.gov/pubmed/204364606 `% I& h- ]- ]0 ?

4 O# O% b- O% c4.PLoS One. 2010 Mar 24;5(3):e9838.
6 E3 E* R& R  Q# Q/ S0 e/ U$ cDirect reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.: R, ~0 w% W# ?. G4 v6 O9 w- b- l
Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.
' B5 w$ C* ?" @
* N( i- e+ O+ @, mMolecular Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America.( P  Q3 a. p5 I) [( B$ h% S( V8 W
http://www.ncbi.nlm.nih.gov/pubmed/20352099
( W5 c* {5 @% i# ^+ K5 W0 \& m% H
) i; e" v3 E4 R+ `6 s" M) r5 e5.Dev Growth Differ. 2010 Apr;52(3):319-33. Epub 2010 Mar 7.! \6 Z) H4 b- X6 Y' t2 f: h2 k0 C
Direct reprogramming 101.
6 u" L" c, z& k3 V- L: Q7 xTakahashi K.
% ]+ F. `0 g/ o& y$ J
5 H  z  ~0 L' ]1 x# mCenter for iPS cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan. takahash@cira.kyoto-u.ac.jp+ y& E" ]$ D/ }" O' a7 Y
http://www.ncbi.nlm.nih.gov/pubmed/20298260
( @9 p  [* l4 ]7 B5 ]! Q
8 H- |7 o0 S/ u: T3 x# A6.Nature. 2009 Oct 1;461(7264):649-3.- a% Q( u$ Y: `* k! h4 v
Direct reprogramming of human neural stem cells by OCT4., J% l. a7 v; }9 d
Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.
/ B3 p: ~% k. L/ P
. r% m9 ?6 e9 \2 AMax Planck Institute for Molecular Biomedicine, Department of Cell and Developmental Biology, Röntgenstrasse 20, 48149 Münster, NRW, Germany.+ _/ s: A+ }- z- G3 |: b) r- E' H
http://www.ncbi.nlm.nih.gov/pubmed/19718018$ A4 z7 t: X, C2 c) o  A2 c+ I

' b4 y& K& h) X- }0 c5 p$ E: f7.Blood. 2009 Aug 27;114(9):1764-7. Epub 2009 Jun 29.* f5 |, N5 b  O; ~
Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.
  i" R2 [# U9 `. x/ bOkabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K, Ema H, Nakauchi H.
$ C( c) c7 ]+ t
, n! ?$ U; ^6 q' r$ L6 dDivision of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.# n- v8 B+ d) x9 q) g1 t  ^
http://www.ncbi.nlm.nih.gov/pubmed/195646351 j* M4 Z; y* N( `* N) ~

/ A, S3 I4 _6 [: \3 G8.Cell Biol Int. 2009 Dec;33(12):1268-73. Epub 2009 Jun 12.% ~2 F, v3 E* V* R- G
Role of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
# F: W) S; E  n% YChen M, Sun X, Jiang R, Shen W, Zhong X, Liu B, Qi Y, Huang B, Xiang AP, Ge J.
6 v; r6 c. A  N- @- {* X
4 r, L7 I0 f; I9 E0 A0 u) f! ^State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.* D1 D$ C$ Y2 w
http://www.ncbi.nlm.nih.gov/pubmed/19524692
1 ?2 _! h% m8 m+ D1 A$ G
0 g& ?8 z* l8 b& v! |9.Mol Ther. 2009 Jun;17(6):947-53. Epub 2009 Mar 31.
5 a4 q; Y$ h4 u6 M% m( t( oUpping the ante: recent advances in direct reprogramming.
$ z- f$ A1 [: U3 y$ |  ]Müller LU, Daley GQ, Williams DA., \) V3 C: N  x, R2 ~
( \5 _) M/ |: u: f& j2 ?
Department of Medicine, Division of Pediatric Hematology Oncology, Children's Hospital Boston, Boston, Massachusetts 02115, USA.+ R* Z0 }# V( J" h: b$ W
Comment in:6 s+ V7 r) E# H. H. r" w+ S

' c8 v' v; W' T4 G3 XMol Ther. 2009 Jun;17(6):929-30.6 n3 X: A9 v# M9 }) j
http://www.ncbi.nlm.nih.gov/pubmed/19337233
0 }3 R4 ?3 _2 M0 y: L3 {% z' y. [  E+ M+ H& k% N
10.Cell Stem Cell. 2008 Sep 11;3(3):346-53.
* |1 e; D" A. O% @! g- S4 c1 jA drug-inducible system for direct reprogramming of human somatic cells to pluripotency.# L) t" w& s) T
Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R.
4 I3 n# r1 A( k8 {$ j6 e: T' m: E2 u
The Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA.
+ F3 N) m# \4 ?  C$ S" i% M+ |http://www.ncbi.nlm.nih.gov/pubmed/18786421& B+ {5 P, C  w+ J  E- J8 o
; A$ z+ \, m2 z# e
11.Nat Biotechnol. 2008 Aug;26(8):916-24. Epub 2008 Jul 1.
  }0 b. Y' l& }8 U9 PA drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.) h3 I* y6 d* O$ i
Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R./ x2 U# `3 w+ ]
6 `% t/ K: c! I+ v5 N
Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA.
9 o: s# L) r2 l: thttp://www.ncbi.nlm.nih.gov/pubmed/18594521
8 ~6 f' x. w; ]' _% z
( w' k$ D2 U6 g8 ]% X# R, `12.Nature. 2008 Jul 3;454(7200):49-55. Epub 2008 May 28.
$ P8 e7 s( l. l2 w" |9 g8 FDissecting direct reprogramming through integrative genomic analysis.
4 n# p: k* p2 g$ `Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A.3 \7 _- z3 @" v4 Z: d' k, B
& e& A9 _) c" N  a4 s
Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.
. a2 d- n' b* w) y. |http://www.ncbi.nlm.nih.gov/pubmed/18509334+ l+ V1 @& ^- u5 {
7 K& N+ R' w1 n
13.Cell. 2008 Apr 18;133(2):250-64.
4 f, z" L9 _* ]- R, U, vDirect reprogramming of terminally differentiated mature B lymphocytes to pluripotency.& \. ]* `* @- G, ^
Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.- ], O9 I7 P* y( L

7 G. v! l( ?, n9 a. F. _, ~The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
' t& [# O" ?. B% ^+ i" lhttp://www.ncbi.nlm.nih.gov/pubmed/18423197
3 c9 Y" v1 T3 Q6 B" I
: j! a* z8 f6 A6 o, i) d14.Cell Stem Cell. 2008 Feb 7;2(2):151-9.2 n; E6 b9 Y' e. i% N9 y5 |7 e
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
! j9 G3 x0 K) Q. |, L- ZBrambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R.
* q: _8 e* v+ b5 r1 c. o
6 |3 K3 ?$ K+ C: q- y, @Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142, USA.& O1 o# p2 s  y  c! N
http://www.ncbi.nlm.nih.gov/pubmed/18371436* r/ F9 r, u3 f+ L- B" W
# M7 K8 u: R1 I1 m* _
15.Cell Stem Cell. 2008 Jan 10;2(1):10-2. Epub 2007 Dec 13./ m4 w- |; j: y4 Z+ S$ M, u
c-Myc is dispensable for direct reprogramming of mouse fibroblasts.% i7 M1 r) h: Z; h4 c6 c% Q. k
Wernig M, Meissner A, Cassady JP, Jaenisch R.' k+ z5 w$ ^: M  S) H
http://www.ncbi.nlm.nih.gov/pubmed/18371415
; q* l% ?& e5 ^% _' ?6 r7 \
. k5 _, T7 Y; p3 v# d16.Cell Stem Cell. 2007 Dec 13;1(6):593-4.- R6 V7 m% I% B/ W6 t- K
The first direct reprogramming of adult human fibroblasts.
4 G; V0 M2 B3 O5 D- g7 ~1 O/ ZWilmut I.6 l6 b2 b9 |3 U8 E, x# U* W, p4 `2 ]

( `. M: k9 q/ S+ ~4 U* FScottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4SB, UK. ian.wilmut@ed.ac.uk4 p" W% r( u9 F" q" d
http://www.ncbi.nlm.nih.gov/pubmed/183713968 G5 |2 P0 P5 _& G* }7 e
" w7 K2 z* q/ r: H  P
17.Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.
+ c% G7 `" q" v/ ^% L$ UDirect reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
' V; o7 _3 K- X# X6 e8 ]Meissner A, Wernig M, Jaenisch R.$ i4 T8 a) ?$ D7 Z! w

7 i3 c3 r" c" x/ C/ TWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Nine Cambridge Center, Cambridge Massachusetts 02142, USA.
7 q! h9 n: ]+ A/ X9 _% V0 Xhttp://www.ncbi.nlm.nih.gov/pubmed/17724450

张也行

1. Promotion of direct reprogramming by transformation-deficient Myc

张也行

# R, a. q! }) N0 H1 Y0 q
) o( z, [$ e7 R9 A4 i" K
2. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming

张也行

3. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event

张也行

4. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cell

flydayzhu

回复 5# 张也行
0 i. I" X9 D; ?8 y. g2 `- s
. x6 |1 {5 k; I' T. Z4 c6 w谢谢~回学校了啥都下不了基本上。。。。

lixiaodong

17.Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.

lixiaodong

16.Cell Stem Cell. 2007 Dec 13;1(6):593-4.  The first direct reprogramming of adult human fibroblasts.( Q- G& \- c" u3 Y1 K# `5 t1 [" d3 q/ d
Wilmut I

lixiaodong

15.Cell Stem Cell. 2008 Jan 10;2(1):10-2. Epub 2007 Dec 13.4 s0 B) [1 i* d6 w4 `7 U4 N4 }/ d% J
c-Myc is dispensable for direct reprogramming of mouse fibroblasts.
" M) k" |2 u- Z- F! L1 @9 @Wernig M, Meissner A, Cassady JP, Jaenisch R.

lixiaodong

14.Cell Stem Cell. 2008 Feb 7;2(2):151-9.% n: b6 L+ A3 n% h7 k3 Y2 A
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.+ Z) \* Q7 t- U0 S& S# ]